SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-033275
Filing Date
2021-08-17
Accepted
2021-08-17 17:22:25
Documents
1
Period of Report
2021-08-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4036
  Complete submission text file 0000899243-21-033275.txt   5629
Mailing Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135
Business Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135 617-409-5300
YUMANITY THERAPEUTICS, INC. (Issuer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O YUMANITY, INC. 40 GUEST STREET, SUITE 4410 BOSTON MA 02135
Business Address
Wyzga Michael D (Reporting) CIK: 0001877600 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37695 | Film No.: 211184038